UK Companies House feature
LASER VISION SCOTLAND LTD
Cash
£2M
-68.6% vs 2023
Net assets
£11M
+18.9% vs 2023
Employees
75
+7.1% vs 2023
Profit before tax
£2M
-47.8% vs 2023
Profile
- Company number
- SC448890
- Status
- Active
- Incorporation
- 2013-04-30
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86220
- Hubs
- UK Healthcare
Net assets
6-year trend · vs UK Healthcare median
Accounts
6-year trend · latest 2024-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £12,189,320 | £13,543,640 | |
| Operating profit | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | £4,296,254 | £2,241,849 | |
| Net profit | — | — | — | — | £3,351,747 | £1,771,961 | |
| Cash | £2,184,726 | £1,444,934 | £4,283,094 | — | £6,847,915 | £2,148,407 | |
| Total assets less current liabilities | £2,363,723 | £3,444,055 | £4,668,868 | — | £10,073,056 | £12,342,959 | |
| Net assets | £2,176,653 | £3,288,938 | £4,498,707 | — | £9,355,396 | £11,127,357 | |
| Equity | £2,176,653 | £3,288,938 | £4,498,707 | £6,003,649 | £9,355,396 | £11,127,357 | |
| Average employees | 4 | 6 | 10 | — | 70 | 75 | |
| Wages | — | — | — | — | £1,427,728 | £1,982,912 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services Chartered Accountants
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern principle which assumes that the company will continue to function in the foreseeable future. The company is dependent on the continued support of its bankers but there are no indications that this support will not be given.”
Significant events
- “2024 has been a pivotal year in the Company's development and growth. The Edinburgh hub significantly increased surgical capacity, meeting growing patient demand. Glasgow's new state-of-the-art facility opened in Q1 2025. Company acquired additional sites as part of regional expansion strategy. Reinvested cash into expansion of surgical capacity, fit-out and commissioning of new facilities, and acquisition of additional sites.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MANTRY, Dipali | Director | 2016-06-01 | Oct 1972 | British |
| MANTRY, Sanjay | Director | 2013-04-30 | Aug 1968 | British |
| ROSS, Jonathan James, Dr | Director | 2013-04-30 | Sep 1974 | British |
| ROSS, Sarah Elizabeth | Director | 2016-06-01 | Mar 1975 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Sanjay Mantry | Individual | Shares 25–50% | 2016-04-06 | Active |
| Dr Jonathan James Ross | Individual | Shares 25–50% | 2016-04-06 | Active |
Filing timeline
Last 20 of 58 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-05-01 | CS01 | confirmation-statement | confirmation statement with updates |
| 2026-03-12 | AA | accounts | accounts with accounts type full |
| 2026-01-07 | DISS40 | gazette | gazette filings brought up to date |
| 2025-12-09 | GAZ1 | gazette | gazette notice compulsory |
| 2025-04-30 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-09-27 | AA | accounts | accounts with accounts type total exemption full |
| 2024-04-30 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-02-02 | PSC04 | persons-with-significant-control | change to a person with significant control |
| 2024-02-02 | CH01 | officers | change person director company with change date |
| 2024-02-02 | PSC04 | persons-with-significant-control | change to a person with significant control |
| 2024-02-02 | CH01 | officers | change person director company with change date |
| 2024-02-02 | CH01 | officers | change person director company with change date |
| 2024-02-02 | CH01 | officers | change person director company with change date |
| 2024-02-02 | AD01 | address | change registered office address company with date old address new address |
| 2024-02-01 | CH01 | officers | change person director company with change date |
| 2024-02-01 | CH01 | officers | change person director company with change date |
| 2024-02-01 | CH01 | officers | change person director company with change date |
| 2024-02-01 | CH01 | officers | change person director company with change date |
| 2023-10-18 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-09-29 | AA | accounts | accounts with accounts type total exemption full |
Credit score
Altman Z″ (private-firm) · reference 2024-12-31
4.19
SAFE
Altman Z″
- Working capital / Total assets 0.127 × 6.56 = +0.83
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.135 × 6.72 = +0.91
- Book equity / Total liabilities 2.331 × 1.05 = +2.45
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory